Skip to main content

Legend Biotech Corp ADR(LEGN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low27.50
Day High29.62
Open:28.34
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
H.C. Wainwright Reaffirms Their Buy Rating on Legend Biotech (LEGN)
Motley Fool
Legend Biotech (LEGN) Q1 2026 Earnings Transcript
MarketBeat
Legend Biotech Q1 Earnings Call Highlights
MarketBeat.com
GlobeNewswire
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
Motley Fool
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
Motley Fool
Matthews Just Slashed Its Futu Position -- Here’s Why That Matters
GlobeNewswire
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
GlobeNewswire
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Legend Biotech (LEGN), Tonix Pharma (TNXP)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Cardiff Oncology (CRDF), Revolution Medicines (RVMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)
Motley Fool
Why Legend Biotech Stock Crushed the Market on Monday
Tipranks
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Ovid Therapeutics (OVID) and Legend Biotech (LEGN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Legend Biotech (LEGN) and Inogen (INGN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Legend Biotech (LEGN)
Tipranks
Legend Biotech Reports Preliminary Q1 2026 CARVYKTI Sales of About $597 Million
Tipranks
RBC Capital Sticks to Their Buy Rating for Legend Biotech (LEGN)
Tipranks
Legend Biotech Earnings Call Highlights CARVYKTI Momentum
Motley Fool
Legend Biotech (LEGN) Q4 2025 Earnings Transcript

Profile

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.